CD274 and cancer: The improved pharmacokinetic properties, rapid renal clearance, and lower radiation exposure suggest that [18F]AlF-NOTA-PCP2 is a highly sensitive and specific tool for noninvasive quantification of PD-L1 levels, with significant potential for enhancing the precision of cancer immunotherapy.